Exela Technologies, Inc. (XELA)
| Previous close | 0.7770 |
| Open | 0.8450 |
| Bid | 0.8430 x 800 |
| Ask | 0.8500 x 800 |
| Day's range | 0.7700 - 0.8848 |
| 52-week range | 0.0860 - 1.1500 |
| Volume | 27,080,258 |
| Avg. volume | 9,922,676 |
| Market cap | 122.139M |
| Beta (5Y monthly) | 2.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.6870 |
| Earnings date | 10 Nov 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.55 |
- Simply Wall St.
Exela Technologies' (NASDAQ:XELA) Stock Price Has Reduced 89% In The Past Three Years
Over the last month the Exela Technologies, Inc. ( NASDAQ:XELA ) has been much stronger than before, rebounding by 71...
- GlobeNewswire
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and STAAR Surgical Company (NASDAQ: STAA) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Peabody Energy Corporation (NYSE: BTU) Bragar Eagel & Squire is investigating certain officers and directors of Peabody Energy Corporation following a class action complaint that was filed against Peabody on September 28, 2020.The complaint alleges that from April 3, 2017 through September 28, 2018, defendants failed to disclose, and would continue to omit, the following adverse facts pertaining to the safety practices at the Company’s North Goonyella mine, which were known to or recklessly disregarded by defendants: (i) the Company had failed to implement adequate safety controls at the North Goonyella mine to prevent the risk of a spontaneous combustion event; (ii) the Company failed to follow its own safety procedures; and (iii) as a result, the North Goonyella mine was at a heightened risk of shutdown.For more information on the Peabody investigation go to: https://bespc.com/cases/BTUEQT Corporation (NYSE: EQT)Bragar Eagel & Squire is investigating certain officers and directors of EQT corporation following a class action complaint that was filed against EQT on June 25, 2019.The complaint alleges that during the class period defendants falsely stated that EQT's acquisition of Rice, a rival gas producer, would yield billions of dollars in synergies based on purported operational benefits. Specifically, on June 19, 2017, defendants announced that EQT had entered into an agreement to acquire Rice for $6.7 billion. Defendants represented that because Rice had an acreage footprint largely contiguous to EQT's existing acreage, the acquisition would allow EQT to achieve "a 50% increase in average lateral [drilling] lengths" (as opposed to more traditional vertical well drilling). EQT claimed that as a result, the merger would result in $2.5 billion in synergies, including $100 million in cost savings in 2018 alone. After the closing in November 2017, the company continued to tout the "significant operational synergies" of the merger. As a result of defendants' misrepresentations, EQT shares traded at artificially inflated prices throughout the class period.To learn more about our investigation into EQT Corporation go to: https://bespc.com/cases/EQTExela Technologies, Inc. (NASDAQ: XELA) Bragar Eagel & Squire is investigating certain officers and directors of Exela Technologies following a class action complaint that was filed against Exela on March 23, 2020.The complaint alleges that throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Exela’s previously issued financial statements for the twelve months ended December, 31, 2017 and December 31, 2018, and the quarterly statements for the three and nine months ended September 30, 2019 contained numerous accounting errors, could not be relied upon, and required restatement; and (2) as a result, Defendants’ statements about Exela’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.To learn more about our investigation into Exela Technologies go to: https://bespc.com/cases/XELASTAAR Surgical Company (NASDAQ: STAA) Bragar Eagel & Squire is investigating certain officers and directors of STAAR Surgical Company following a class action complaint that was filed against STAAR on August 19, 2020.The complaint alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts to investors. Specifically, defendants misrepresented and/or failed to disclose to investors that the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) defendants’ public statements were materially false and misleading at all relevant times.To learn more about our investigation into STAAR go to: https://bespc.com/cases/STAAAbout Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.Contact Information: Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Melissa Fortunato, Esq. Marion Passmore, Esq. (212) 355-4648 investigations@bespc.com www.bespc.com
- GlobeNewswire
Exela Technologies Engages UBS Investment Bank to Explore Strategic Alternatives
IRVING, Texas, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a location-agnostic global business process automation (BPA) leader, announced that it has retained UBS Investment Bank as an additional financial advisor to assist the Company and management in pursuing alternatives to strengthen its balance sheet and enhance shareholder value. The Company will make any future announcements related to this release as events dictate.About Exela TechnologiesExela Technologies is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of expertise operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. With foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry department solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and public sectors. Through cloud-enabled platforms, built on a configurable stack of automation modules, and over 21,000 employees operating in 23 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner. Forward-Looking Statements Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "may", "should", "would", "plan", "intend", "anticipate", "believe", "estimate", "predict", "potential", "seem", "seek", "continue", "future", "will", "expect", "outlook" or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, estimated or anticipated future results and benefits, future opportunities for Exela, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading "Risk Factors" in Exela's Annual Report and other securities filings. In addition, forward-looking statements provide Exela's expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela's assessments to change. These forward-looking statements should not be relied upon as representing Exela's assessments as of any date subsequent to the date of this press release.Investor and/or Media Contacts: Vincent Kondaveeti E: vincent.kondaveeti@exelatech.com T: 929-620-1849Mary Beth Benjamin E: IR@exelatech.com T: 646-277-1216
